Ron Shapiro, Professor of surgery at the Thomas E. Starzl Institute of University of Pittsburgh Medical Center discusses the recently published multicenter study of Absorbers' endothelial crossmatch, XM-ONE, at a video blog at Medscape.com. Professor Shapiro refers to the test as very simple to use and straightforward. He further states that anti-endothelial cell antibodies has been a difficult area and says that the development of XM-ONE is very interesting and important in the clinical care of kidney transplant patients and potentially also other organ transplant recipients.
To listen to the blog please follow the link: http://www.medscape.com/viewarticle/701601
AbSorber's transplantation crossmatch test XM-ONE® was evaluated in a large clinical study and the results are now published in the prestigious international medical journal "Transplantation". The study shows that XM-ONE® contributes valuable information that refines the diagnostics for finding the right organ for the right patient, thereby increasing the probability of a successful transplantation. Four U.S. and two Swedish well-reputed hospitals participated in the multicenter trial. For further information about the multicenter study please visit previous press releases.